These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7816875)

  • 21. The dopamine D1 receptor antagonist SCH 23390 can exert D1 agonist-like effects on rat nucleus accumbens neurons.
    Wachtel SR; White FJ
    Neurosci Lett; 1995 Oct; 199(1):13-6. PubMed ID: 8584215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation.
    Marin C; Chase TN
    Eur J Pharmacol; 1993 Feb; 231(2):191-6. PubMed ID: 8095897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of haloperidol and SCH 23390 with cocaine and dopamine receptor subtype-selective agonists on schedule-controlled behavior of squirrel monkeys.
    Witkin JM; Schindler CW; Tella SR; Goldberg SR
    Psychopharmacology (Berl); 1991; 104(4):425-31. PubMed ID: 1838199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1995 Feb; 273(3):229-33. PubMed ID: 7737329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
    Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of dopamine D1 and D2 receptors in the nucleus accumbens in jaw movements of rats: a critical role of the shell.
    Cools AR; Miwa Y; Koshikawa N
    Eur J Pharmacol; 1995 Nov; 286(1):41-7. PubMed ID: 8566150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T; Todo N; Sasa M
    Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D2 receptor agents, but not dopamine D1, modify brain glucose metabolism.
    Palacios JM; Wiederhold KH
    Brain Res; 1985 Feb; 327(1-2):390-4. PubMed ID: 3157422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies.
    Abarca J; Gysling K; Roth RH; Bustos G
    Neurochem Res; 1995 Feb; 20(2):159-69. PubMed ID: 7783840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
    Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
    Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats.
    Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani A
    J Psychopharmacol; 2003 Dec; 17(4):415-23. PubMed ID: 14870954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of selective dopamine D1- and D2-agonists and antagonists on timing performance in rats.
    Frederick DL; Allen JD
    Pharmacol Biochem Behav; 1996 Apr; 53(4):759-64. PubMed ID: 8801575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D2 and D1 dopaminergic activity of 7-OH-DPAT.
    Sethy VH; Ellerbrock BR; Fici GJ; Wu H
    Brain Res; 1996 Sep; 733(1):41-5. PubMed ID: 8891246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE; Holtzman SG
    Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of D-1 receptor system on the D-2 receptor-mediated hypothermic response in mice.
    Menon MK; Gordon LI; Kodama CK; Fitten J
    Life Sci; 1988; 43(10):871-81. PubMed ID: 2901020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D1 and D2 effects on fetal mouthing responses to milk.
    Smotherman WP; Robinson SR
    Physiol Behav; 1995 Jan; 57(1):15-9. PubMed ID: 7878109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393.
    Terry P; Katz JL
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):328-33. PubMed ID: 7862841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.